UniSuper Management Pty Ltd Has $4.13 Million Holdings in Aflac Incorporated (NYSE:AFL)

UniSuper Management Pty Ltd lifted its stake in shares of Aflac Incorporated (NYSE:AFL) by 28.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,907 shares of the financial services provider’s stock after purchasing an additional 8,890 shares during the period. UniSuper Management Pty Ltd’s holdings in Aflac were worth $4,128,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Whipplewood Advisors LLC acquired a new position in Aflac during the 4th quarter worth $26,000. BankPlus Trust Department acquired a new position in Aflac during the 4th quarter valued at about $34,000. Curio Wealth LLC bought a new position in shares of Aflac in the 4th quarter valued at about $36,000. Raelipskie Partnership acquired a new stake in shares of Aflac during the 3rd quarter worth approximately $38,000. Finally, OFI Invest Asset Management bought a new stake in shares of Aflac during the fourth quarter worth approximately $38,000. 67.44% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Aflac Trading Down 1.0 %

AFL opened at $109.71 on Friday. The stock has a market capitalization of $59.88 billion, a P/E ratio of 11.43, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The firm’s fifty day simple moving average is $106.49 and its 200 day simple moving average is $107.66.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have commented on AFL shares. JPMorgan Chase & Co. lifted their target price on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Evercore ISI dropped their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Keefe, Bruyette & Woods decreased their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Morgan Stanley increased their price target on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Finally, Barclays decreased their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.